未登录.png)
分享.png)
收藏Bicalutamide ('Casodex') 150 mg in addition to standard care in patients with nonmetastatic prostate cancer:: updated results from a randomised double-blind phase III study (median follow-up 5.1 y) in the early prostate cancer programme
Wirth, M; Tyrrell, C; Delaere, K; Sánchez-Chapado, M; Ramon, J; Wallace, DMA; Hetherington, J; Pina, F; Heyns, C; Borchers, T; Morris, T; Armstrong, J 分享 收藏 Suicide gene therapy using adenovirus encoded nitroreductase (NTR) and CB1954 in patients with localized Prostate CancerPatel, P; Mautner, V; Young, JG; Jackson, D; Hull, D; Badhan, A; Searle, PF; Mountain, A; Ellis, J; Peers, E; Doherty, AP; Wallace, DMA; Leung, HY; Young, LS; James, ND 分享 收藏 分享 收藏 Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: First analysis of the early prostate cancer programSee, WA; Wirth, MP; McLeod, DG; Iversen, P; Klimberg, I; Gleason, D; Chodak, G; Montie, J; Tyrrell, C; Wallace, DMA; Delaere, KPJ; Vaage, S; Tammela, TLJ; Lukkarinen, O; Persson, BE; Carroll, K; Kolvenbag, GJCM 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
